Home/Filings/4/0001604643-23-000082
4//SEC Filing

Fages Herve 4

Accession 0001604643-23-000082

CIK 0001604643other

Filed

May 25, 8:00 PM ET

Accepted

May 26, 4:27 PM ET

Size

13.8 KB

Accession

0001604643-23-000082

Insider Transaction Report

Form 4
Period: 2023-05-24
Fages Herve
Executive Vice President
Transactions
  • Award

    Common Stock

    2023-05-24+23,45575,975 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-2414,9380 total
    Exercise: $13.91Exp: 2029-03-01Common Stock (14,938 underlying)
  • Disposition to Issuer

    Common Stock

    2023-05-2475,9750 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-2420,6440 total
    Exercise: $23.63Exp: 2030-02-14Common Stock (20,644 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-05-2425,0620 total
    Exercise: $24.76Exp: 2031-02-16Common Stock (25,062 underlying)
Footnotes (7)
  • [F1]Represents performance share units ("PSUs") that became earned (at target award level) pursuant to the merger agreement among Xylem Inc., Fore Merger Sub, Inc. and the issuer, dated as of Jan. 22, 2023, upon effectiveness of the merger on May 24, 2023.
  • [F2]Disposed of pursuant to the merger agreement. Upon effectiveness of the merger, (i) each issued and outstanding share of issuer common stock was exchanged for 0.48 Xylem common shares, with cash paid in lieu of fractional shares, and (ii) unvested restricted stock units ("RSUs") and PSUs (at target award level) were converted into RSUs relating to Xylem common shares, by multiplying the number of shares of issuer common stock underlying the award and 0.48, rounded down to the nearest whole share.
  • [F3]This option is fully vested.
  • [F4]Pursuant to the merger agreement, outstanding options for issuer common stock were assumed by Xylem and converted into options for Xylem common shares, in an amount equal to the number of shares of issuer common stock underlying the options multiplied by 0.48, rounded down to the nearest whole share.
  • [F5]Pursuant to the merger agreement, the Xylem option exercise price is equal to the issuer option exercise price divided by 0.48, rounded up to the nearest whole cent.
  • [F6]This option vests in four equal annual installments starting on Jan. 1, 2021.
  • [F7]This option vests in four equal annual installments starting on Feb. 16, 2022.

Issuer

Evoqua Water Technologies Corp.

CIK 0001604643

Entity typeother

Related Parties

1
  • filerCIK 0001768653

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:27 PM ET
Size
13.8 KB